Comparison of methods for incorporating a radioiodinated residualizing cholesteryl ester analog into low density lipoprotein

Laura E. Deforge , Mark R. Degalan , Mohamed K. Ruyan , Roger S. Newton , Raymond E. Counsell
{"title":"Comparison of methods for incorporating a radioiodinated residualizing cholesteryl ester analog into low density lipoprotein","authors":"Laura E. Deforge ,&nbsp;Mark R. Degalan ,&nbsp;Mohamed K. Ruyan ,&nbsp;Roger S. Newton ,&nbsp;Raymond E. Counsell","doi":"10.1016/0883-2897(92)90139-P","DOIUrl":null,"url":null,"abstract":"<div><p>Two different methods were evaluated for incorporating [<sup>125</sup>I]cholesteryl iopanoate ([<sup>125</sup>I]CI), a non-hydrolyzable cholesteryl ester analog, into LDL. The first procedure was an organic solvent delipidation-reconstitution procedure (R[<sup>125</sup>I-CI]LDL) while the second involved incubation of detergent (Tween-20)-solubilized [<sup>125</sup>I]CI with whole plasma (D[<sup>125</sup>I-CI]LDL). R[<sup>125</sup>I-CI]LDL behaved similar to native LDL <em>in vitro</em>, but was markedly different <em>in vivo</em>, apparently due to a heterogeneity in particle size. D[<sup>125</sup>I-CI]LDL, however, was metabolized normally both <em>in vitro</em> and <em>in vivo</em>. These results, combined with the residualizing nature of [<sup>125</sup>I]CI, demonstrate that D[<sup>125</sup>I-CI]LDL is appropriate for tracing LDL uptake <em>in vivo</em>.</p></div>","PeriodicalId":14328,"journal":{"name":"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology","volume":"19 7","pages":"Pages 775-782"},"PeriodicalIF":0.0000,"publicationDate":"1992-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0883-2897(92)90139-P","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/088328979290139P","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Two different methods were evaluated for incorporating [125I]cholesteryl iopanoate ([125I]CI), a non-hydrolyzable cholesteryl ester analog, into LDL. The first procedure was an organic solvent delipidation-reconstitution procedure (R[125I-CI]LDL) while the second involved incubation of detergent (Tween-20)-solubilized [125I]CI with whole plasma (D[125I-CI]LDL). R[125I-CI]LDL behaved similar to native LDL in vitro, but was markedly different in vivo, apparently due to a heterogeneity in particle size. D[125I-CI]LDL, however, was metabolized normally both in vitro and in vivo. These results, combined with the residualizing nature of [125I]CI, demonstrate that D[125I-CI]LDL is appropriate for tracing LDL uptake in vivo.

将放射性碘化残馀化胆固醇酯类似物掺入低密度脂蛋白的方法比较
两种不同的方法被评估纳入[125I]胆甾醇嘌呤酸酯([125I]CI),一种不可水解的胆固醇酯类似物,到低密度脂蛋白。第一个步骤是有机溶剂脱溶-重构程序(R[125I-CI]LDL),第二个步骤是将洗涤剂(Tween-20)溶解的[125I]CI与整个血浆(D[125I-CI]LDL)孵育。R[125I-CI]LDL在体外表现与天然LDL相似,但在体内表现明显不同,这显然是由于颗粒大小的异质性。然而,D[125I-CI]LDL在体内和体外代谢正常。这些结果,结合[125I]CI的残留特性,表明D[125I-CI]LDL适合于追踪LDL在体内的摄取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信